Assessment of Antihypertensive Effect by Blood Pressure Monitoring: Applications to Bisoprolol and Lisinopril in a Double-Blind Study
The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 m...
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular pharmacology 1997-05, Vol.29 (5), p.612-617 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The aim of this study was to evaluate the antihypertensive effect of drugs according to the initial ambulatory blood pressure (BP) level. After a 15-day placebo run-in period, 105 patients with moderate essential hypertension (mean age, 52 years) underwent 24-h BP monitoring (spacelabs1 measure/15 min). Patients were subdivided into two groupsthe "High" group, with 24-h mean values of systolic BP (SBP) >137 or diastolic BP (DBP) >87 mm Hg, and the "Low" group, with SBP ≤ 137 and DBP ≤ 87 mm Hg. All patients received, in a random and double-blind design, either bisoprolol (10 mg q.d.) or lisinopril (20 mg q.d.) for 8 weeks. At the end of this active treatment period office and ambulatory BP measurements were performed. Casual measurements revealed similar BP decreases in all subgroups receiving bisoprolol and lisinopril; BP monitoring showed that the antihypertensive effect depended on the baseline mean 24-h value; −15/−12 mm Hg for bisoprolol and −18/−13 mm Hg for lisinopril in the High group; −7/−6 mm Hg for bisoprolol and −6/−6 mm Hg for lisinopril in the Low group. This study shows that the antihypertensive effect depended on initial ambulatory BP values, with a lower BP decrease in the Low group. Assessment of the antihypertensive effect on ambulatory BP is useful in clinical trials. |
---|---|
ISSN: | 0160-2446 1533-4023 |
DOI: | 10.1097/00005344-199705000-00008 |